AwardedSpainGoods€1,856,230
Suministro de medicamentos biosimilares Ustekinumab, Ranibizumab y Eculizumab para el Sector de Huesca.
- Published
- Published 24 March 2025
- Deadline
- Closed 5 May 2025
Overview
Suministro de medicamentos biosimilares Ustekinumab, Ranibizumab y Eculizumab para el Sector de Huesca.
Vigencia del 1 de septiembre de 2025 al 31 de agosto de 2026 o 12 meses desde su formalización.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €1,856,230
- Procedure
- Open
- Published
- 24 March 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- €282,400
- Award date
- 5 September 2025
- Contract period
- 1 September 2025 → 31 August 2026
- ACCORD HEALTHCARE, SLU
- AMGEN,S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
7 October 2025
Contract Award Notice
11 August 2025
Contract Notice
2 May 2025
Contract Notice
24 March 2025
Contracting authority
Gerencia Sector Sanitario de Huesca
Procuring entityHuesca, Spain
ID_PLATAFORMA: 20997570143517
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.